⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863193 | 1.00 | — | — | |
| SCHEMBL12940068 | 1.00 | — | — | |
| SCHEMBL14963190 | 0.79 | — | — | |
| SCHEMBL13716272 | 0.75 | — | — | |
| SCHEMBL7837665 | 0.75 | — | — | |
| SCHEMBL3214461 | 0.73 | — | — | |
| SCHEMBL127505 | 0.72 | SLC6A2 (0.31) | — | |
| SCHEMBL18019736 | 0.71 | — | — | |
| SCHEMBL436289 | 0.69 | — | — | |
| SCHEMBL9678445 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167109-A1 | Aminopiperidine Amides, Derivatives, Compositions, and Uses Related to CXCR4 Modulation | UNIV EMORY (US) | 2023-06-01 | — | — | US | claimed |
| WO-2021217143-A1 | AMINOPIPERIDINE AMIDES, DERIVATIVES, COMPOSITIONS, AND USES RELATED TO CXCR4 MODULATION | EMORY UNIVERSITY (US) | 2021-10-28 | — | — | WO | claimed |
| CN-110372080-A | The inorganic agent of combined removal heavy metals in industrial wastewater ion | 重庆工程职业技术学院 | 2019-10-25 | — | — | CN | claimed |
| EP-1140942-B1 | PRENYL TRANSFERASE INHIBITORS | CONSEILS DE RECH SET D APPLIC (FR) | 2004-03-10 | — | — | EP | claimed |
| US-4719231-A | 3-[N-(mercaptoacyl)]amino-4-arylbutanoic acid derivatives and an analgesic agent comprising the same | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1988-01-12 | — | — | US | claimed |
| WO-2024013355-A1 | HYDROGELS FOR CELL THERAPY | ADOCIA (FR) | 2024-01-18 | — | — | WO | disclosed |
| EP-4306550-A1 | HYDROGELS FOR CELL THERAPY | Adocia (FR) | 2024-01-17 | — | — | EP | disclosed |
| US-11779602-B2 | Methods of use for CAR T cells | ENDOCYTE, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11779602-B2 | Methods of use for CAR T cells | ENDOCYTE, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11759480-B2 | Compositions and methods for CAR T cell therapy | ENDOCYTE, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230167109-A1 | Aminopiperidine Amides, Derivatives, Compositions, and Uses Related to CXCR4 Modulation | UNIV EMORY (US) | 2023-06-01 | — | — | US | disclosed |
| US-11311625-B2 | Peptide-based multiple-drug delivery vehicle | ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2022-04-26 | — | — | US | disclosed |
| WO-2007022494-A2 | MULTI-DRUG LIGAND CONJUGATES | ENDOCYTE, INC. (US) | 2007-02-22 | — | — | WO | disclosed |
| WO-2007022493-A2 | LIGAND CONJUGATES OF VINCA ALKALOIDS, ANALOGS, AND DERIVATIVES | ENDOCYTE, INC. (US) | 2007-02-22 | — | — | WO | disclosed |
| EP-1140942-B1 | PRENYL TRANSFERASE INHIBITORS | CONSEILS DE RECH SET D APPLIC (FR) | 2004-03-10 | — | — | EP | disclosed |
| CN-1021910-C | LANKACIDIN DERIVATIVES AND PRODUCTION THEREOF | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1993-08-25 | — | — | CN | disclosed |
| EP-0382411-A2 | Delivery of cytotoxic agents | ELI LILLY AND COMPANY (US) | 1990-08-16 | — | — | EP | disclosed |
| US-4719231-A | 3-[N-(mercaptoacyl)]amino-4-arylbutanoic acid derivatives and an analgesic agent comprising the same | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1988-01-12 | — | — | US | disclosed |
| CN-86108176-A | Lankacidin derivatives and process for producing the same | — | 1987-10-21 | — | — | CN | disclosed |
| US-4212795-A | TO FORM DISULFIDE BOND | ARMOUR PHARMACEUTICAL COMPANY (US) | 1980-07-15 | — | — | US | disclosed |